Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- SymBio Decides on Its First Development Product
January 9, 2006
- BUSINESS NEWS IN BRIEF
January 9, 2006
- Bayer Receives "Low Carbon Leaders Award"
January 9, 2006
- R&D NEWS IN BRIEF
January 9, 2006
- SEMINAR
January 9, 2006
- NEW PRODUCTS
January 9, 2006
- 3 Associations Draft Proposal on Med. Device Safety Management
January 9, 2006
- STATISTICS
January 9, 2006
- ACCJ Calls For Improvement in Review of Medical Devices
January 9, 2006
- ＜New Year's Greeting＞PhRMA to Work to More Quickly Bring Innovative Drugs to Patients
January 9, 2006
- MEDICAL DEVICE NEWS IN BRIEF
January 9, 2006
- Surprise Free Forecasts For 2006
January 9, 2006
- REGULATORY NEWS IN BRIEF -2-
December 26, 2005
- Blopress Retains No. 1 Ranking, Lipitor Takes No. 2 Spot
December 26, 2005
- Takeda Becomes Alfresa HD's Top Supplier
December 26, 2005
- BUSINESS NEWS IN BRIEF
December 26, 2005
- SSP's Consumer Healthcare Division Targeting Female Consumers
December 26, 2005
- Subcommittee Approves Recommendations on Sale of OTC Drugs
December 26, 2005
- Tailor-made Bone That Can Be Shaped in Any Form Developed by UT Group
December 26, 2005
- Drugs, Medical Materials to See 1.8% Price Cut on the Basis of Medical Expenditure
December 26, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…